Formulations for transmucosal vaginal delivery of bisphosphonates
US6905701B2 · kind B2 · utility
6Cited by
1References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 22, 2003 |
| Grant date | Jun 14, 2005 |
| Priority date | — |
| Expiry date | May 25, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Devices, methods, and improved formulation for transmucosal vaginal delivery of bisphosphonates. A targeted site delivery of bisphosphonates to the systemic circulation using a vaginal device comprising an improved bisphosphonate formulation for transmucosal delivery. A method for treatment of osteoporosis and related bone and skeleton diseases, for prevention of bone breakdown and loss of bone mass and strength by intravaginal administration of bisphosphonates to the vagina and transmucosal delivery of bisphosphonates to the general circulation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.